# Enveda

Company record · Presspool · https://presspool.ai/companies/enveda-com

Enveda is a clinical-stage biotechnology company that uses AI to identify molecules made by living organisms and develop them into oral medicines. Website: https://enveda.com

## Funding

Latest announced financing: $311 million, Series E, led by Catalio Capital Management, announced September 23, 2026.
- Listed in the [AI startup funding roster for September 21–26, 2026](https://presspool.ai/ai-startup-funding/week-of-2026-09-21).

## Whether AI names Enveda

- Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to September 25, 2026.

A company counts when an AI answer names it or cites its website. Answers vary from run to run, so each count is a dated sample.

## Sources

- [Enveda](https://enveda.com/news/enveda-raises-311-million/)
- [TechCrunch](https://techcrunch.com/2026/09/23/enveda-secures-311m-to-bring-more-nature-derived-ai-drugs-into-clinical-trials/)

---

Presspool is an independent record of AI startup funding. Rounds are listed because they were publicly announced, and no company pays to be listed. Who publishes it and how it stays independent: [About](https://presspool.ai/about).

More: [Tracker](https://presspool.ai/) · [Niches](https://presspool.ai/niches) · [Method](https://presspool.ai/method) · [About](https://presspool.ai/about) · [Contact](https://presspool.ai/contact) · [llms.txt](https://presspool.ai/llms.txt)